The Medical Letter - 2017
Year:    Publication:      2017 Annual Index: U.S. English | Canadian English
January 2, 2017 (Issue 1511)  
  • Antiviral Drugs for Seasonal Influenza 2016-2017
    Superseded by The Medical Letter "Antiviral Drugs for Seasonal Influenza 2017-2018" - Issue 1537, January 1, 2018Antiviral drugs can be used for prophylaxis and treatment of influenza....
  • Another Insulin Glargine (Basaglar) for Diabetes
    The FDA has approved Basaglar (Lilly/Boehringer Ingelheim), a "follow-on" 100 units/mL insulin glargine product similar to Lantus (Sanofi), which recently went off patent. A 300...
  • Ustekinumab (Stelara) for Crohn's Disease
    The FDA has approved the human interleukin (IL)-12 and -23 antagonist ustekinumab (Stelara – Janssen Biotech) for treatment of moderately to severely active Crohn's disease in adults who...
  • Tenofovir Alafenamide (Vemlidy) for Hepatitis B
    The FDA has approved tenofovir alafenamide (Vemlidy – Gilead) for treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease. It is the first...
January 16, 2017 (Issue 1512)  
  • Drugs for Type 2 Diabetes
    The goal of drug therapy for type 2 diabetes is to achieve and maintain a near-normal glycated hemoglobin (A1C) concentration without inducing hypoglycemia; the target is generally an A1C...
January 30, 2017 (Issue 1513)  
February 13, 2017 (Issue 1514)  
February 27, 2017 (Issue 1515)  
March 13, 2017 (Issue 1516)  
  • Drugs for Hypertension
    in the US and their dosages, adverse effects, and costs are listed in the tables. Treatment of hypertensive urgencies and emergencies is not discussed here.
March 27, 2017 (Issue 1517)  
April 10, 2017 (Issue 1518)  
April 24, 2017 (Issue 1519)  
May 8, 2017 (Issue 1520)  
May 22, 2017 (Issue 1521)  
June 5, 2017 (Issue 1522)  
June 19, 2017 (Issue 1523)  
July 3, 2017 (Issue 1524)  
  • Drugs for Sexually Transmitted Infections
    The text and tables that follow include recommendations for management of sexually transmitted infections (STIs) other than HIV and viral hepatitis. Some of the indications and dosages...
July 17, 2017 (Issue 1525)  
July 31, 2017 (Issue 1526)  
August 14, 2017 (Issue 1527)  
August 28, 2017 (Issue 1528)  
September 11, 2017 (Issue 1529)  
September 25, 2017 (Issue 1530)  
October 9, 2017 (Issue 1531)  
October 23, 2017 (Issue 1532)  
November 6, 2017 (Issue 1533)  
November 20, 2017 (Issue 1534)  
December 4, 2017 (Issue 1535)  
December 18, 2017 (Issue 1536)